How successful are we in relieving terminal dyspnea in cancer patients? A real-world multicenter prospective observational study
ConclusionsOverall, terminal dyspnea was relatively well controlled with parenteral morphine, though a significant number of patients continued to suffer from dyspnea. Future efforts are needed to improve outcomes following standardized dyspnea treatment using patient-reported outcomes for imminently dying patients.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Japan Health | Lung Cancer | Morphine | Palliative | Palliative Care | Study